Join Mailing List   |   Print Page   |   Contact Us   |   Sign In   |   Join
International Factor XIII Symposium
Tell a Friend About This EventTell a Friend

When: 2/12/2014
Where: Vienna

« Go to Upcoming Event List  

The program of the the IFXIIIS 2014 in Vienna

Venue: Hofburg Congress Center, Heldenplatz 1010, Vienna, Austria

Date: Wednesday, 12 February 2014

Time: 09:00–12:00

Room: Forum

Title: "Recent Advances in Molecular Pathogenesis of FXIII-related Diseases"

Chairs: A. Ichinose (Yamagata, JP), H.-P. Kohler (Bern, CH)


1) Need for Recommendations for Diagnosis of Congenital FXIII Deficiency in Countries with Limited Resources by Verena Schroeder, Kohler HP (Bern Univ. Hospital, CH).

2) Alloantibody in a FXIII-A Deficient Patient with Fatal Outcome; Characterization of the Antibody by Laszlo Muszbek, Pénzes K, Vezina C, Bereczky Z, Katona É, Rivard GE (Univ. Debrecen, Hungary; Centre Hospitalier Universitaire, Canada)

3) FXIII Overexpression in Partial Trisomies by Alessandro Castiglione, Guaran V, Astolfi L, Orioli E, Zeri G, Gemmati D, Bovo R, Montaldi A, Alghisi A, Martini A (Padua University Hospital, Italy)

4) Sushi Domains: Not Only a Complement Protein Domain by Arijit Biswas (Bonn Univ., Germany)

5) Molecular Studies on Acquired Hemorrhaphilia Due to Anti-FXIII Autoantibodies (AH13) by Akitada Ichinose, Souri M, Osaki T, Sugiyama D, Magari Y (Yamagata Univ.; Q-may, Japan)

6) Tocilizumab Induced Acquired FXIII Deficiency in Patients with Rheumatoid Arthritis by Sho Mokuda, Murata Y, Sawada N, Matoba K, Yamada A, Onishi M, Okuda Y, Jouyama K, Sugiyama E, Takasugi K (Hiroshima University Hospital, Japan)

7) The Functions of FXIII in Inflammatory Bowel Diseases (tentative title) by Christoffer Søndergaard, Kvist PH, Seidelin JB, Nielsen OH (Herlev Hospital, Denmark)

8) FXIII and Urticaria: a Novel Mechanism in the Pathogenesis? by Paulo Ricardo Criado (Sao Paulo University, Brazil)

9) Fibrin Matrices, FXIII and Tissue Factor Effects on in Early-term Trophoblast Proliferation and Spreading by Benjamin Brenner, Snir A, Paz B, Ohel G, Lanir N (Bnai-Zion Medical Center; Israel Institute of Technology, Israel)

10) Multiple Ligands of von Willebrand Factor-binding Protein (vWbp) Promote Staphylococcus aureus Clot Formation in Human Plasma by Dominique Missiakas, Thomer L, Schneewind O (Univ. Chicago, USA)

11) FXIII-A in Energy Metabolism

by Mari Kaartinen (MacGill Univ., Canada)

12) Oxidative Modification of Fibrinogen and Plasma Fibrin-stabilizing Factor by Anna V Bychkova, Mark A. Rosenfeld, Shchegolikhin AN, Leonova VB, Biryukova MI, Kostanova EA (N.M. Emanuel Institute of Biochemical Physics, Russia)

13) Methodological Considerations of Working with FXIII and Fibrinogen by Helen Philippou, Ariëns RA (Univ. Leeds, UK)



If you have any questions, please do not hesitate to contact us (mailing address:

Membership Management Software Powered by YourMembership  ::  Legal